Free Trial
OTCMKTS:CYDY

CytoDyn (CYDY) Stock Price, News & Analysis

CytoDyn logo
$0.26 +0.00 (+1.23%)
As of 03:59 PM Eastern

About CytoDyn Stock (OTCMKTS:CYDY)

Advanced

Key Stats

Today's Range
$0.26
$0.27
50-Day Range
$0.24
$0.37
52-Week Range
$0.10
$0.49
Volume
1.38 million shs
Average Volume
2.65 million shs
Market Capitalization
$331.31 million
P/E Ratio
26.33
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CytoDyn Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

CYDY MarketRank™: 

CytoDyn scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CytoDyn.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CytoDyn is 26.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.81.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CytoDyn is 26.03, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.44.

  • Read more about CytoDyn's valuation and earnings.
  • Percentage of Shares Shorted

    2.99% of the outstanding shares of CytoDyn have been sold short.
  • Short Interest Ratio / Days to Cover

    CytoDyn has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in CytoDyn has recently increased by 0.09%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    CytoDyn does not currently pay a dividend.

  • Dividend Growth

    CytoDyn does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.99% of the outstanding shares of CytoDyn have been sold short.
  • Short Interest Ratio / Days to Cover

    CytoDyn has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in CytoDyn has recently increased by 0.09%, indicating that investor sentiment is decreasing.
  • News Sentiment

    CytoDyn has a news sentiment score of -0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for CytoDyn this week, compared to 1 article on an average week.
  • Search Interest

    Only 2 people have searched for CYDY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added CytoDyn to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CytoDyn insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.54% of the stock of CytoDyn is held by insiders.

  • Percentage Held by Institutions

    Only 5.06% of the stock of CytoDyn is held by institutions.

  • Read more about CytoDyn's insider trading history.
Receive CYDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CYDY Stock News Headlines

September 2025 Letter to Shareholders
CytoDyn to present poster at AACR conference on mTNBC
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
See More Headlines

CYDY Stock Analysis - Frequently Asked Questions

CytoDyn's stock was trading at $0.1097 at the start of the year. Since then, CYDY stock has increased by 137.0% and is now trading at $0.26.

CytoDyn Inc. (OTCMKTS:CYDY) announced its earnings results on Friday, July, 25th. The biotechnology company reported ($0.01) EPS for the quarter.

Shares of CYDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CytoDyn investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AU Optronics (AUOTY) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
7/25/2025
Today
10/02/2025
Next Earnings (Estimated)
10/15/2025
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CYDY
Previous Symbol
NASDAQ:CYDY
CIK
1175680
Fax
N/A
Employees
20
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
$0.01
Trailing P/E Ratio
25.89
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.74 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-4.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.25

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.00 per share
Price / Cash Flow
78.03
Book Value
($0.08) per share
Price / Book
-3.23

Miscellaneous

Outstanding Shares
1,259,750,000
Free Float
1,252,950,000
Market Cap
$325.77 million
Optionable
Not Optionable
Beta
1.37

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:CYDY) was last updated on 10/2/2025 by MarketBeat.com Staff
From Our Partners